Due to this pro-tumorigenic effect, LDLR expression has been shown to be a predictor of tumour progression and survival with studies of breast cancer and small-cell lung cancer patients exhibiting better survival rates in those whose tumours demonstrated low LDLR expression [22,23]. The gene discussed is LDLR; the disease is breast carcinoma.